RPG Life Sciences (Small Cap - Potential Multibagger) Share Target 2025, 2026 To 2035
|
RPG Life Sciences Limited |
|||
|
Price: ₹2,345.55 (+3.34%) | ||
| 52 Week Low: ₹1,360.00 52 Week High: ₹2,974.95 |
|||
| Market Capital: 2,449.42 Crore (Smallcap) | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: RPG Life Sciences Share Price Target For 2025
- 1.1.1: RPG Life Sciences Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: RPG Life Sciences Share Price Target For 2026
- 1.2.1: RPG Life Sciences Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: RPG Life Sciences Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: RPG Life Sciences Brief Company Overview
- 4: RPG Life Sciences Financial Performance
- 4.0.1: Is RPG Life Sciences A Good Buy For Long Term?
RPG Life Sciences, a Small Cap company in the Drug Manufacturers—Specialty & Generic Industry has delivered 881.8% returns in 5-year showing 7.2% quarterly revenue growth with 15.1% profit margin, making it a potential Multibagger.
To predict the RPG Life Sciences's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
RPG Life Sciences Share Price Target For 2025
The line chart displays the monthly closing prices of RPG Life Sciences with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for RPG Life Sciences shares in 2025, see the table below.
RPG Life Sciences Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 2656.1 (+13.23%) | Price Action: 15 Oct 2024 Low |
| 2025 Target 2 | 2623.95 (+11.86%) | Price Action: 07 Nov 2024 Low |
| 2025 Target 1 | 2595.55 (+10.65%) | Price Action: 24 Oct 2024 High |
| Current Price | 2345.55 | RPG Life Sciences's share price as of 25 Feb 2025 |
| Stop Loss 1 | 2235.0 (-4.72%) | Price Action: 02 Jan 2025 High |
| Stop Loss 2 | 2211.1 (-5.74%) | Price Action: 17 Dec 2024 Low |
| Stop Loss 3 | 2186.0 (-6.81%) | Price Action: 06 Dec 2024 Low |
Short-Term Technical Outlook
Current Technical Position: RPG Life Sciences is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 25-day moving average at ₹2328.77 serves as the nearest technical reference point.
Historical Returns: 3-month: +5.78% | 6-month: +11.4% | 1-year: +56.15%
RPG Life Sciences Share Price Target For 2026
The line chart displays the monthly closing prices of RPG Life Sciences with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for RPG Life Sciences shares in 2026, see the table below.
RPG Life Sciences Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 3912.02 (+66.78%) | Price Action: Chart |
| 2026 Target 2 | 3839.08 (+63.67%) | Price Action: Chart |
| 2026 Target 1 | 3801.07 (+62.05%) | Fibonacci Extension Level 64.90% |
| Current Price | 2345.55 | RPG Life Sciences's share price as of 25 Feb 2025 |
| Stop Loss 1 | 2013.0 (-14.18%) | Price Action: 21 Nov 2024 Low |
| Stop Loss 2 | 1987.85 (-15.26%) | Price Action: 31 Jul 2024 High |
| Stop Loss 3 | 1960.0 (-16.44%) | Price Action: 07 Aug 2024 High |
Long-Term Technical Outlook
52-Week Range Analysis: RPG Life Sciences is currently trading at 61.0% of its 52-week range (₹1360 - ₹2974.95).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +56.15% | 3-year: +371.51% | 5-year: +881.81%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
RPG Life Sciences Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹2,345.55 | ||
| 2025 | ₹3,718.22 | +58.52% | ₹3,773.99 |
| 2026 | ₹5,693.81 | +53.13% | ₹5,779.22 |
| 2027 | ₹8,466.04 | +48.68% | ₹8,593.03 |
| 2028 | ₹13,584.31 | +60.45% | ₹13,788.07 |
| 2029 | ₹20,925.39 | +54.04% | ₹21,239.27 |
| 2030 | ₹30,457.06 | +45.55% | ₹30,913.92 |
| 2031 | ₹41,656.85 | +36.77% | ₹42,281.70 |
| 2032 | ₹55,984.51 | +34.39% | ₹56,824.28 |
| 2033 | ₹75,902.35 | +35.57% | ₹77,040.89 |
| 2034 | ₹96,907.46 | +27.67% | ₹98,361.07 |
| 2035 | ₹121,651.13 | +25.53% | ₹123,475.90 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
RPG Life Sciences Brief Company Overview
RPG Life Sciences Limited: A Renowned Pharmaceutical Company RPG Life Sciences Limited is an integrated pharmaceutical company that develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and...
internationally. Founded in 1968, they have established a strong reputation in the industry. Key Products and Services Synthetic APIs in various therapeutic categories Generics primarily in immunosuppressant therapy Finished dosage formulations for various therapies RPG Life Sciences Limited operates across a diverse range of therapeutic areas, including nephrology, rheumatology, and gastroenterology. They are committed to providing high-quality, affordable healthcare solutions.RPG Life Sciences Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 2,449.42 Crore | Market valuation of RPG Life Sciences's shares. |
| Revenue (TTM) | 582.04 Crore | Total revenue generated by RPG Life Sciences over the past twelve months. |
| Net Income (TTM) | +87.66 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +12.78% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +15.06% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+7.19% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+27.9% | Change in earnings compared to the same quarter last year. |
| Total Cash | 126.62 Crore | Total amount of liquid funds available to RPG Life Sciences. |
| Beta | 0.48 | Beta is less than 1 indicating that the RPG Life Sciences's price is less volatile than the market. |
Is RPG Life Sciences A Good Buy For Long Term?
RPG Life Sciences shows strong growth potential with a consistent rise in earnings and revenue. Its impressive profit margin and robust cash balance indicate financial stability. Over the past five years, it has delivered exceptional returns, making it a promising long-term investment opportunity. Based on its financial performance and growth prospects, RPG Life Sciences is a good buy for investors seeking long-term growth in their portfolio.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
